Hormone exposure and venous thromboembolism in commercially insured women aged 50 to 64 years.

Research and practice in thrombosis and haemostasis(2023)

引用 1|浏览5
暂无评分
摘要
The risk of VTE is much lower with MHT than combined hormone contraceptives and varies by hormone formulation and route of exposure. Transdermal MHT did not elevate risk. Oral MHT combinations with estradiol were lower risk than other forms of estrogen. Oral combined hormone contraceptives had much higher risk than oral combined hormonal MHT.
更多
查看译文
关键词
venous thromboembolism,hormone,women
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要